Importantly, recent longitudinal analyses of participants within the AD Neuroimaging Initiative (ADNI) demonstrated evidence for synergism between Aβ and Tau, suggesting that these pathologies may interact to trigger the progression from amnestic mild cognitive impairment (MCI) to AD dementia3–5,38–40. This evidence concerns the gene MAPT and Alzheimer disease.